• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Precision Oncology Program for Cancer of the Prostate (POPCaP) Network: A Veterans Affairs/Prostate Cancer Foundation Collaboration.前列腺癌精准肿瘤学项目(POPCaP)网络:退伍军人事务部/前列腺癌基金会合作项目
Fed Pract. 2020 Aug;37(Suppl 4):S48-S53. doi: 10.12788/fp.0021.
2
Leveraging Veterans Health Administration Clinical and Research Resources to Accelerate Discovery and Testing in Precision Oncology.利用退伍军人健康管理局的临床和研究资源,加速精准肿瘤学的发现与测试。
Fed Pract. 2020 Aug;37(Suppl 4):S62-S67. doi: 10.12788/fp.0028.
3
Prostate Cancer Foundation-Department of Veterans Affairs Partnership: A Model of Public-Private Collaboration to Advance Treatment and Care of Invasive Cancers.前列腺癌基金会与退伍军人事务部合作项目:公私合作推进侵袭性癌症治疗与护理的典范。
Fed Pract. 2020 Aug;37(Suppl 4):S32-S37. doi: 10.12788/fp.0035.
4
Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.退伍军人事务部放射肿瘤学质量监测项目和美国放射肿瘤学会专家小组制定的前列腺癌共识质量指标与剂量限制
Pract Radiat Oncol. 2023 Mar-Apr;13(2):e149-e165. doi: 10.1016/j.prro.2022.08.018. Epub 2022 Dec 9.
5
The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer Medicine.退伍军人事务部即时护理精准肿瘤项目:在分子癌症医学中平衡可及性与快速学习
Biomark Cancer. 2016 Feb 29;8:9-16. doi: 10.4137/BIC.S37548. eCollection 2016.
6
VA National Precision Oncology Program.美国退伍军人事务部国家精准肿瘤项目
Fed Pract. 2020 Aug;37(Suppl 4):S22-S27. doi: 10.12788/fp.0037.
7
VA-Radiation Oncology Quality Surveillance Program.VA-放射肿瘤学质量监督计划。
Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):639-647. doi: 10.1016/j.ijrobp.2019.08.064. Epub 2020 Jan 23.
8
The National Cancer Institute and Department of Veterans Affairs Interagency Group to Accelerate Trials Enrollment (NAVIGATE): A federal collaboration to improve cancer care.美国国家癌症研究所和退伍军人事务部机构间加速试验招募组(NAVIGATE):一项旨在改善癌症护理的联邦合作。
Semin Oncol. 2019 Aug-Oct;46(4-5):308-313. doi: 10.1053/j.seminoncol.2019.09.005. Epub 2019 Oct 22.
9
The Veterans Precision Oncology Data Commons: Transforming VA data into a national resource for research in precision oncology.退伍军人精准肿瘤学数据公共平台:将退伍军人事务部的数据转化为精准肿瘤学研究的国家资源。
Semin Oncol. 2019 Aug-Oct;46(4-5):314-320. doi: 10.1053/j.seminoncol.2019.09.002. Epub 2019 Oct 2.
10
Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative.退伍军人事务部放射肿瘤学质量监测计划和美国放射肿瘤学会质量措施倡议。
Pract Radiat Oncol. 2022 Nov-Dec;12(6):468-474. doi: 10.1016/j.prro.2022.05.015. Epub 2022 Jun 8.

引用本文的文献

1
The translation-to-policy learning cycle to improve public health.用于改善公共卫生的翻译到政策的学习循环。
Learn Health Syst. 2024 Oct 11;8(4):e10463. doi: 10.1002/lrh2.10463. eCollection 2024 Oct.
2
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing.适应社会生态模型以解决黑人男性参与前列腺癌基因检测的差异问题。
BMC Public Health. 2024 Sep 18;24(1):2533. doi: 10.1186/s12889-024-20008-8.
3
The foundational science of learning health systems.学习型健康系统的基础科学。
Health Serv Res. 2024 Dec;59(6):e14374. doi: 10.1111/1475-6773.14374. Epub 2024 Aug 20.
4
Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care Systems.社区贫困程度、种族和民族与加利福尼亚医疗保健系统中前列腺癌治疗效果的关系。
JAMA Netw Open. 2024 Mar 4;7(3):e242852. doi: 10.1001/jamanetworkopen.2024.2852.
5
Prostate Cancer Foundation-Department of Veterans Affairs Partnership: A Model of Public-Private Collaboration to Advance Treatment and Care of Invasive Cancers.前列腺癌基金会与退伍军人事务部合作项目:公私合作推进侵袭性癌症治疗与护理的典范。
Fed Pract. 2020 Aug;37(Suppl 4):S32-S37. doi: 10.12788/fp.0035.
6
Introduction: Precision Oncology Changes the Game for VA Health Care.简介:精准肿瘤学改变了退伍军人医疗保健的局面。
Fed Pract. 2020 Aug;37(Suppl 4):S9-S10. doi: 10.12788/fp.0039.
7
Foreword.前言。
Fed Pract. 2020 Aug;37(Suppl 4):S8-S9. doi: 10.12788/fp.0038.

本文引用的文献

1
Leveraging Veterans Health Administration Clinical and Research Resources to Accelerate Discovery and Testing in Precision Oncology.利用退伍军人健康管理局的临床和研究资源,加速精准肿瘤学的发现与测试。
Fed Pract. 2020 Aug;37(Suppl 4):S62-S67. doi: 10.12788/fp.0028.
2
Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies.转移性前列腺癌中错配修复缺陷:对 PD-1 阻断和标准疗法的反应。
PLoS One. 2020 May 26;15(5):e0233260. doi: 10.1371/journal.pone.0233260. eCollection 2020.
3
Olaparib for Metastatic Castration-Resistant Prostate Cancer.奥拉帕利治疗转移性去势抵抗性前列腺癌。
N Engl J Med. 2020 May 28;382(22):2091-2102. doi: 10.1056/NEJMoa1911440. Epub 2020 Apr 28.
4
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.分析前列腺癌中微卫星不稳定性的流行情况及对免疫检查点阻断的反应。
JAMA Oncol. 2019 Apr 1;5(4):471-478. doi: 10.1001/jamaoncol.2018.5801.
5
Sequencing Therapy for Genetically Defined Subgroups of Non-Small Cell Lung Cancer.针对非小细胞肺癌基因定义亚组的序贯治疗
Am Soc Clin Oncol Educ Book. 2018 May 23;38:726-739. doi: 10.1200/EDBK_201331.
6
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.转移性前列腺癌的基因组特征和结构变异。
Cell. 2018 Jul 26;174(3):758-769.e9. doi: 10.1016/j.cell.2018.06.039. Epub 2018 Jul 19.
7
DNA-Repair Gene Mutations in Metastatic Prostate Cancer.转移性前列腺癌中的DNA修复基因突变
N Engl J Med. 2016 Nov 3;375(18):1804-5. doi: 10.1056/NEJMc1611137.
8
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.转移性前列腺癌男性患者的遗传性DNA修复基因突变
N Engl J Med. 2016 Aug 4;375(5):443-53. doi: 10.1056/NEJMoa1603144. Epub 2016 Jul 6.
9
Integrative clinical genomics of advanced prostate cancer.晚期前列腺癌的整合临床基因组学
Cell. 2015 May 21;161(5):1215-1228. doi: 10.1016/j.cell.2015.05.001.
10
Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis.林奇综合征患者患前列腺癌的风险:一项系统评价和荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):437-49. doi: 10.1158/1055-9965.EPI-13-1165. Epub 2014 Jan 14.

前列腺癌精准肿瘤学项目(POPCaP)网络:退伍军人事务部/前列腺癌基金会合作项目

The Precision Oncology Program for Cancer of the Prostate (POPCaP) Network: A Veterans Affairs/Prostate Cancer Foundation Collaboration.

作者信息

Montgomery Bruce, Rettig Matthew, Kasten Jesse, Muralidhar Sumitra, Myrie Kenute, Ramoni Rachel

机构信息

is an Oncologist and is Network Director at VA Puget Sound Health Care System in Seattle, Washington. is an Oncologist at the Greater Los Angeles Health Care System and a Professor of Medicine at the University of California, Los Angeles. is Program Director, Million Veteran Program. is Scientific Program Manager of Oncology and is Chief Research and Development Officer, all in the Office of Research and Development, Veterans Health Administration. Bruce Montgomery is a Professor of Medicine at the University of Washington in Seattle.

出版信息

Fed Pract. 2020 Aug;37(Suppl 4):S48-S53. doi: 10.12788/fp.0021.

DOI:10.12788/fp.0021
PMID:32908353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7473728/
Abstract

BACKGROUND

The promise of precision oncology only can be realized when genetic alterations are identified that can be lever-aged to improve response and minimize toxicity. Identifying those alterations as efficiently as possible and then giving patients access to targeted therapy and clinical study requires a comprehensive strategy across health care systems.

OBSERVATIONS

The US Department of Veterans Affairs (VA) and Prostate Cancer Foundation have established a network of VA centers to help develop best practices for precision oncology for the treatment of veterans with advanced prostate cancer. This article describes the genesis and structure of this network and its potential for contributing to care and research in the VA and the health care system as a whole.

CONCLUSIONS

The Precision Oncology Program for Cancer of the Prostate network and its partnership with VA clinical and research efforts is anticipated to provide important insights into barriers and solutions to the implementation of precision oncology for prostate cancer across the VA.

摘要

背景

只有当识别出可用于改善反应并将毒性降至最低的基因改变时,精准肿瘤学的前景才能实现。尽可能高效地识别这些改变,然后让患者能够获得靶向治疗和参与临床研究,这需要整个医疗保健系统采取全面的策略。

观察结果

美国退伍军人事务部(VA)和前列腺癌基金会已经建立了一个VA中心网络,以帮助制定针对晚期前列腺癌退伍军人的精准肿瘤学最佳实践。本文描述了该网络的起源、结构及其对VA以及整个医疗保健系统的护理和研究做出贡献的潜力。

结论

前列腺癌精准肿瘤学项目网络及其与VA临床和研究工作的合作,有望为VA系统中前列腺癌精准肿瘤学实施的障碍和解决方案提供重要见解。